Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 2018

View Archived Issues

Nudt15-knockout mouse model shown useful to guide thiopurine dosing in ALL

Atara Biotherapeutics announces initiation of phase III clinical program for tabelecleucel

First patient dosed in phase III trial of tislelizumab in HCC

Cascadian Therapeutics receives pediatric investigation plan waiver from EMA for tucatinib

NexImmune closes series A financing to support initiation of phase I/II trial of AIM ACT

IQGAP1 identified as a potential therapeutic target for AML treatment

Protalix BioTherapeutics reports interim data from phase II study of OPRX-106

FDA grants priority review to Achaogen's plazomicin NDA

Centrexion Therapeutic raises funds for phase III development of CNTX-4975

Five Prime initiates phase I portion of FIGHT trial of FPA-144 in advanced gastric cancer

FDA grants breakthrough therapy designation to Kisqali for premenopausal breast cancer

Achaogen reports topline results from first clinical trial of C-Scape

Tetraphase submits NDA for intravenous eravacycline to treat cIAI

FDA accepts Olinvo NDA

New anti-BCMA-CAR therapy for MM shows promise in preclinical phase

Addex and Indivior sign licensing and collaboration agreement for ADX-71441 to treat addiction

SciFluor Life Sciences patents novel KCNQ2/3 activators

Chinese researchers disclose kappa-opioid receptor agonists

Enanta Pharmaceuticals identifies anti-HBV compounds

Bayer presents novel IRAK-4 inhibitors

New TBK1 and IKK-E inhibitors presented by Bayer

Researchers present novel BALB/c mouse model of PRV infection

Galapagos updates status of cystic fibrosis pipeline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...